Zealand Pharma A/S

NASDAQ: ZEAL · Real-Time Price · USD
17.59
0.00 (0.00%)
At close: Sep 29, 2022, 10:00 PM

Zealand Pharma A/S Income Statement

Financials in DKK. Fiscal year is January - December.
Fiscal Year FY 2021
Period Ending Dec 31, 2021
Revenue
292.57M
Cost of Revenue
118.81M
Gross Profit
173.75M
Operating Income
-1.02B
Interest Income
44K
Pretax Income
-1.03B
Net Income
-1.02B
Selling & General & Admin
636.26M
Research & Development
588.45M
Other Expenses
-759K
Operating Expenses
1.22B
Interest Expense
4.09M
Selling & Marketing Expenses
375.27M
Cost & Expenses
1.34B
Income Tax Expense
-8.79M
Shares Outstanding (Basic)
38.37M
Shares Outstanding (Diluted)
38.37M
EPS (Basic)
-26.54
EPS (Diluted)
-26.54
EBITDA
-982.6M
EBIT
-1.02B
Depreciation & Amortization
40.25M